Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct

This study is currently recruiting participants.
Verified March 2013 by Institut Paoli-Calmettes
Sponsor:
Information provided by (Responsible Party):
Institut Paoli-Calmettes
ClinicalTrials.gov Identifier:
NCT01499537
First received: September 16, 2011
Last updated: March 19, 2013
Last verified: March 2013

September 16, 2011
March 19, 2013
January 2011
January 2014   (final data collection date for primary outcome measure)
Morbidity rate [ Time Frame: 30 days ] [ Designated as safety issue: Yes ]
Morbidity rate during 30 post-operative days
Same as current
Complete list of historical versions of study NCT01499537 on ClinicalTrials.gov Archive Site
  • efficacy [ Time Frame: 15 days ] [ Designated as safety issue: No ]
    decrease of bilirubine > 50%
  • feasibility [ Time Frame: up to 3 days ] [ Designated as safety issue: No ]
    succes or not of the intervention to obtain bilairy drainage
  • biliary drainage duration [ Time Frame: up to 1 month ] [ Designated as safety issue: No ]
    time between intervention and drain withdrawal
  • quality of life [ Time Frame: 30 days ] [ Designated as safety issue: No ]
    QLQ-C30 questionnary at inclusion and at D30
Same as current
Not Provided
Not Provided
 
Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct
Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct in Patients With Malignant or Post-operative Jaundice After Failure or Impossibility to Perform Endoscopic Retrograde Cholangiography

At this time, endoscopic retrograde cholangiopancreatography (ERCP) stay the gold standard method to achieve biliary drainage in case of malignant or benign stricture. When ERCP fail or if the major papilla is not suitable, percutaneous transhepatic biliary drainage (PTBD) is the most commonly used alternative, surgery having higher morbidity and mortality rates, unacceptable especially in palliative situation. Recent developments in interventional endoscopic ultrasonography (EUS) allow new endoluminal approaches to pancreatic-biliary structures, such as cysto-enterostomy or pancreatic-enterostomy. More recently were described the possibility to realize EUS-guided biliary drainage, through the duodenal or the gastric wall. Advantages of the EUS-guided approach are to be realizable even the papilla is not suitable endoscopically (duodenal stricture or post-surgical status) and to allow if necessary extra-tumoral non anatomic drainage (hepaticogastrostomy). This technique is actually an alternative to PTBD. In comparison of the PTBD, EUS-guided route seems to have less morbidity and to avoid external biliary drainage. Indeed, the morbidity rate of the percutaneous biliary drainage and the EUS-guided biliary drainage range respectively from 25 to 35% and from 0 to 23%. However, none study compare prospectively both techniques. Aims of this study are to compare the morbidity rate, feasibility and efficacy of these techniques.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Jaundice
  • Device: biliary drainage
    percutaneous transhepatic biliary drainage (PTBD)
    Other Name: biliary drainage
  • Device: EUS guided biliary drainage
    endoscopic ultrasonography guided biliary drainage through the duodenal or the gastric wall
    Other Name: EUS guided biliary drainage
  • Active Comparator: Percutaneous Drainage
    Percutaneous Transhepatic Biliary Drainage (PTBD)
    Intervention: Device: biliary drainage
  • Experimental: EUS-guided drainage
    endoscopic ultrasonography guided biliary drainage through the duodenal or the gastric wall
    Intervention: Device: EUS guided biliary drainage
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
110
February 2014
January 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age >= 18
  • Karnofsky >= 50%
  • biliary stenosis (malignant or benign stricture)with failure of endoscopic retrograde cholangiopancreatography
  • signed informed consent

Exclusion Criteria:

  • isolated biliary stenosis of right hepatic canal
  • percutaneous biliary drainage < 10 days
  • laparotomy < 10 days
  • contra-indication to the procedure
  • pregnant women
Both
18 Years and older
No
Contact: Dominique GENRE, MD +33491223778 bec@marseille.fnclcc.fr
Contact: Agnès BOYER CHAMMARD, MD +33491223778 bec@marseille.fnclcc.fr
France,   Monaco
 
NCT01499537
APHAGE/IPC 2010-002
No
Institut Paoli-Calmettes
Institut Paoli-Calmettes
Not Provided
Principal Investigator: Erwan BORIES, MD Institut Paoli-Calmettes
Institut Paoli-Calmettes
March 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP